Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus

Neuropharmacology

Volumn 67, Issue , 2013, Pages 294-303

  Mercier, Marion S ^a   Lodge, David ^a   Fang, Guangyu ^a   Nicolas, Celine S ^a   Collett, Valerie J ^a   Jane, David E ^a   Collingridge, Graham L ^a   Bortolotto, Zuner A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

DCPG; Dentate gyrus; Lateral perforant path; MDCPG; Medial perforant path; Metabotropic glutamate receptors; mGlu8

Indexed keywords

3,4 DICARBOCYPHENYLGLYCINE; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; IC 50; MALE; NONHUMAN; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REACTION TIME; RECEPTOR DOWN REGULATION; RESPONSE TIME; SYNAPTIC TRANSMISSION;

AMINO ACIDS; AMINO ACIDS, DICARBOXYLIC; ANIMALS; BICYCLO COMPOUNDS; DENTATE GYRUS; FEMALE; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL PATHWAYS; PERFORANT PATHWAY; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; XANTHENES;

EID: 84873327473     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.11.020     Document Type: Article

References (45)

1. K. Abitbol, F. Acher, and H. Daniel Depression of excitatory transmission at PF-PC synapse by group III metabotropic glutamate receptors is provided exclusively by mGluR4 in the rodent cerebellar cortex J. Neurochem. 105 2008 2069 2079
2. W.W. Anderson, and G.L. Collingridge Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions J. Neurosci. Methods 162 2007 346 356
3. P. Bäckström, and P. Hyytiä Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3, 4-DCPG Eur. J. Pharmacol. 528 2005 110 118
4. M. Broadstock, P. Austin, M. Betts, and S. Duty Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata Br. J. Pharmacol. 165 2011 1034 1045
5. T. Bushell, D. Jane, H. Tse, J. Watkins, J. Garthwaite, and G. Collingridge Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices Br. J. Pharmacol. 117 1996 1457 1462
6. L. Ceolin, S. Kantamneni, G.R.I. Barker, L. Hanna, L. Murray, E.C. Warburton, E.S.J. Robinson, J.A. Monn, S.M. Fitzjohn, and G.L. Collingridge Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a wistar substrain with an anxiety-like phenotype J. Neurosci. 31 2011 6721 6731
7. G. Collingridge, S. Kehl, and H. McLennan The action of some analogues of the excitatory amino acids in the dentate gyrus of the rat Can. J. Physiol. Pharmacol. 62 1984 424 429
8. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
9. L. Dawson, A. Chadha, M. Megalou, and S. Duty The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat Br. J. Pharmacol. 129 2000 541 546
10. R.M. Duvoisin, T. Pfankuch, J.M. Wilson, J. Grabell, V. Chhajlani, D.G. Brown, E. Johnson, and J. Raber Acute pharmacological modulation of mGluR8 reduces measures of anxiety Behav. Brain Res. 212 2010 168 173
11. J. Folbergrová, R. Druga, R. Haugvicová, P. Mares, and J. Otáhal Anticonvulsant and neuroprotective effect of (S)-3, 4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid Neuropharmacology 54 2008 665 675
12. J. Folbergrová, J. Otáhal, and R. Druga Brain superoxide anion formation in immature rats during seizures: protection by selected compounds Exp. Neurol. 233 2012 421 429
13. R. Gereau Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability J. Neurophysiol. 74 1995 122 129
14. L. Hanna, L. Ceolin, S. Lucas, J. Monn, B. Johnson, G. Collingridge, Z. Bortolotto, and D. Lodge Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist Neuropharmacology 66 2013 114 121
15. E. Hermans, R. Challiss, and S.R. Nahorski Effects of varying the expression level of recombinant human mGlu1α receptors on the pharmacological properties of agonists and antagonists Br. J. Pharmacol. 126 1999 873 882
16. D. Hoyer, and H. Boddeke Partial agonists, full agonists, antagonists: dilemmas of definition Trends Pharmacol. Sci. 14 1993 270 275
17. D.R. Ireland, and W.C. Abraham Group I mGluRs increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent mechanism J. Neurophysiol. 88 2002 107 116
18. D.E. Jane, P.L. Jones, P.C. Pook, H.W. Tse, and J.C. Watkins Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord Br. J. Pharmacol. 112 1994 809 816
19. P.J. Jones, Z. Xiang, and P.J. Conn Metabotropic glutamate receptors mGluR4 and mGluR8 regulate transmission in the lateral olfactory tract-piriform cortex synapse Neuropharmacology 55 2008 440 446
20. T.P. Kenakin Pharmacologic Analysis of Drug-receptor Interaction 1993 Raven Press New York
21. J. Kilbride, L.Q. Huang, M.J. Rowan, and R. Anwyl Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV Eur. J. Pharmacol. 356 1998 149 157
22. A. Kingston, P. Ornstein, R. Wright, B. Johnson, N. Mayne, J. Burnett, R. Belagaje, S. Wu, and D. Schoepp LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors Neuropharmacology 37 1998 1 12
23. A.M. Linden, M. Bergeron, M. Baez, and D.D. Schoepp Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice Neuropharmacology 45 2003 473 483
24. A.M. Linden, H. Shannon, M. Baez, J. Yu, A. Koester, and D. Schoepp Anxiolytic-like activity of the mGlu2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice Psychopharmacology 179 2005 284 291
25. T. Macek, D. Winder, and R. Gereau Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses J. Neurophysiol. 76 1996 3798 3806
26. R.B. Mailman GPCR functional selectivity has therapeutic impact Trends Pharmacol. Sci. 28 2007 390 396
27. I. Marabese, V. De Novellis, E. Palazzo, M. Scafuro, D. Vita, F. Rossi, and S. Maione Effects of (S)-3, 4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice Neuropharmacology 52 2007 253 262
28. B. McNaughton Evidence for two physiologically distinct perforant pathways to the fascia dentata Brain Res. 199 1980 1 19
29. R.X. Moldrich, P.M. Beart, D.E. Jane, A.G. Chapman, and B.S. Meldrum Anticonvulsant activity of 3, 4-dicarboxyphenylglycines in DBA/2 mice Neuropharmacology 40 2001 732 735
30. F. Nicoletti, J. Bockaert, G. Collingridge, P. Conn, F. Ferraguti, D. Schoepp, J. Wroblewski, and J. Pin Metabotropic glutamate receptors: from the workbench to the bedside Neuropharmacology 60 2011 1017 1041
31. C.M. Niswender, K.A. Johnson, Q. Luo, J.E. Ayala, C. Kim, P.J. Conn, and C.D. Weaver A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors Mol. Pharmacol. 73 2008 1213 1224
32. E. Palazzo, Y. Fu, G. Ji, S. Maione, and V. Neugebauer Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors Neuropharmacology 55 2008 537 545
33. E. Palazzo, I. Marabese, M. Soukupova, L. Luongo, S. Boccella, C. Giordano, V. de Novellis, F. Rossi, and S. Maione Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain J. Neurosci. 31 2011 4687 4697
34. R.S. Petralia, Y.X. Wang, A.S. Niedzielski, and R.J. Wenthold The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976
35. W. Ren, E. Palazzo, S. Maione, and V. Neugebauer Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala Neuropharmacology 61 2011 1334 1344
36. R. Renden, H. Taschenberger, N. Puente, D.A. Rusakov, R. Duvoisin, L.Y. Wang, K.P. Lehre, and H. von Gersdorff Glutamate transporter studies reveal the pruning of metabotropic glutamate receptors and absence of AMPA receptor desensitization at mature calyx of held synapses J. Neurosci. 25 2005 8482 8497
37. M.J. Robbins, K.R. Starr, A. Honey, E.M. Soffin, C. Rourke, G.A. Jones, F.M. Kelly, J. Strum, R.A. Melarange, and A.J. Harris Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia Brain Res. 1152 2007 215 227
38. G. Sansig, T. Bushell, V. Clarke, A. Rozov, N. Burnashev, C. Portet, F. Gasparini, M. Schmutz, K. Klebs, and R. Shigemoto Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7 J. Neurosci. 21 2001 8734 8745
39. S. Schmid, and M. Fendt Effects of the mGluR8 agonist (S)-3,4-DCPG in the lateral amygdala on acquisition/expression of fear-potentiated startle, synaptic transmission, and plasticity Neuropharmacology 50 2006 154 164
40. D.D. Schoepp, D.E. Jane, and J.A. Monn Pharmacological agents acting at subtypes of metabotropic glutamate receptors Neuropharmacology 38 1999 1431 1476
41. R. Shigemoto, A. Kinoshita, E. Wada, S. Nomura, H. Ohishi, M. Takada, P.J. Flor, A. Neki, T. Abe, S. Nakanishi, and N. Mizuno Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus J. Neurosci. 17 1997 7503 7522
42. N.K. Thomas, R.A. Wright, P.A. Howson, A.E. Kingston, D.D. Schoepp, and D.E. Jane (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord Neuropharmacology 40 2001 311 318
43. J.D. Urban, W.P. Clarke, M. Von Zastrow, D.E. Nichols, B. Kobilka, H. Weinstein, J.A. Javitch, B.L. Roth, A. Christopoulos, and P.M. Sexton Functional selectivity and classical concepts of quantitative pharmacology J. Pharmacol. Exp. Ther. 320 2007 1 13
44. C. Yung-Chi, and W.H. Prusoff Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
45. J. Zhai, M. Tian, Y. Wang, J. Yu, A. Köster, M. Baez, and E. Nisenbaum Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors Neuropharmacology 43 2002 223 230